Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy
出版年份 2021 全文链接
标题
Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy
作者
关键词
-
出版物
iScience
Volume 24, Issue 11, Pages 103297
出版商
Elsevier BV
发表日期
2021-10-19
DOI
10.1016/j.isci.2021.103297
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma
- (2017) Changyu He et al. Oncotarget
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1
- (2016) Jin-Gyoung Jung et al. CANCER RESEARCH
- CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation
- (2016) Yao-An Shen et al. Oncotarget
- ZINC 15 – Ligand Discovery for Everyone
- (2015) Teague Sterling et al. Journal of Chemical Information and Modeling
- The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer
- (2015) Luca Magnani et al. Oncotarget
- Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer
- (2015) Oncotarget
- The cellular thermal shift assay for evaluating drug target interactions in cells
- (2014) Rozbeh Jafari et al. Nature Protocols
- Transcription factor PREP1 induces EMT and metastasis by controlling the TGF- -SMAD3 pathway in non-small cell lung adenocarcinoma
- (2014) M. Risolino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
- (2013) L. Magnani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Defining NOTCH3 Target Genes in Ovarian Cancer
- (2012) X. Chen et al. CANCER RESEARCH
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- FRED and HYBRID docking performance on standardized datasets
- (2012) Mark McGann JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Identification of PBX1 Target Genes in Cancer Cells by Global Mapping of PBX1 Binding Sites
- (2012) Michelle M. Thiaville et al. PLoS One
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
- (2010) Joon Tae Park et al. AMERICAN JOURNAL OF PATHOLOGY
- Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease
- (2010) Pauline Wimberger et al. ANNALS OF SURGICAL ONCOLOGY
- Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
- (2010) Paul C. D. Hawkins et al. Journal of Chemical Information and Modeling
- Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency
- (2009) Hsiang-Yuan Yeh et al. BMC Medical Genomics
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
- Identification ofPbx1, a Potential Oncogene, as a Notch3 Target Gene in Ovarian Cancer
- (2008) Joon T. Park et al. CANCER RESEARCH
- Pbx1 Regulates Self-Renewal of Long-Term Hematopoietic Stem Cells by Maintaining Their Quiescence
- (2008) Francesca Ficara et al. Cell Stem Cell
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More